Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF EXECUTIVE OFFICER

CHIEF FINANCIAL OFFICER

SEE REMARKS

CHIEF BUSINESS OFFICER

KALA BIO, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of eye diseases. The company's product candidates include KPI-012, which is in Phase 2b clinical trial for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development product, including KPI-014 for the treatment of rare inherited retinal diseases. The company was formerly known as Kala Pharmaceuticals, Inc. and changed its name to KALA BIO, Inc. in August 2023. KALA BIO, Inc. was incorporated in 2009 and is headquartered in Arlington, Massachusetts.

KALA BIO, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for ...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-04	Premium	sold	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-01-04	Premium	sold	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-01-04	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-01-04	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2024-01-04	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-01-04	Premium	sold	Premium	Premium	Premium	CHIEF BUSINESS OFFICER
2024-01-04	Premium	acquired	Premium	Premium	Premium	CHIEF BUSINESS OFFICER
2024-01-04	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-01-04	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2024-01-04	Premium	sold	Premium	Premium	Premium	SEE REMARKS
2024-01-04	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2024-01-04	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2023-06-22	Premium	acquired	Premium	Premium	Premium	-
2023-06-22	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2023-06-22	Premium	acquired	Premium	Premium	Premium	-
2023-06-22	Premium	acquired	Premium	Premium	Premium	-
2023-06-22	Premium	acquired	Premium	Premium	Premium	-
2023-06-22	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2023-06-22	Premium	acquired	Premium	Premium	Premium	-
2023-06-22	Premium	acquired	Premium	Premium	Premium	CHIEF FINANCIAL OFFICER
2023-06-22	Premium	acquired	Premium	Premium	Premium	CHIEF BUSINESS OFFICER
2023-06-22	Premium	acquired	Premium	Premium	Premium	CHIEF EXECUTIVE OFFICER
2023-06-22	Premium	acquired	Premium	Premium	Premium	-
2023-06-22	Premium	acquired	Premium	Premium	Premium	SEE REMARKS
2023-05-31	Premium	acquired	Premium	Premium	Premium	-

KALA - Kala Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for KALA